R. Ihaddadene

Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.

A. Delluc, G. Le Gal, M. Carrier, 2014, Thrombosis research.

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.

J. Douketis, S. Solymoss, R. Zarychanski, 2015, Blood.

Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus

C. Canil, G. Le Gal, M. Carrier, 2014, Journal of thrombosis and haemostasis : JTH.

The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety

M. Carrier, R. Ihaddadene, 2016, Expert opinion on drug safety.

Diagnosis of Venous Thromboembolism: 20 Years of Progress

P. Wells, M. Forgie, A. Reilly, 2018, Annals of Internal Medicine.

The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus

C. Canil, A. Delluc, G. Le Gal, 2014, Journal of thrombosis and haemostasis : JTH.

The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety

M. Carrier, R. Ihaddadene, 2016, Expert opinion on drug safety.